salvinorin a has been researched along with 6-(1,3-benzodioxol-5-yl)-N-methyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine in 1 studies
Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (6-(1,3-benzodioxol-5-yl)-N-methyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine) | Trials (6-(1,3-benzodioxol-5-yl)-N-methyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine) | Recent Studies (post-2010) (6-(1,3-benzodioxol-5-yl)-N-methyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine) |
---|---|---|---|---|---|
247 | 7 | 128 | 5 | 0 | 5 |
Protein | Taxonomy | salvinorin a (IC50) | 6-(1,3-benzodioxol-5-yl)-N-methyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine (IC50) |
---|---|---|---|
Dual specificity protein kinase CLK1 | Homo sapiens (human) | 0.011 | |
Dual specificity protein kinase CLK2 | Homo sapiens (human) | 0.173 | |
Dual specificity protein kinase CLK3 | Homo sapiens (human) | 4.949 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.031 | |
Dual specificity protein kinase CLK4 | Homo sapiens (human) | 0.012 | |
Dual specificity tyrosine-phosphorylation-regulated kinase 1B | Homo sapiens (human) | 0.073 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
1 other study(ies) available for salvinorin a and 6-(1,3-benzodioxol-5-yl)-N-methyl-N-(thiophen-2-ylmethyl)-4-quinazolinamine
Article | Year |
---|---|
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |